Maxalt, containing the active ingredient rizatriptan, is available by prescription only in Israel [1].
What is Maxalt prescribed for?
Maxalt is prescribed for the acute treatment of migraine with or without aura in adults [1]. It is important to note that it is not intended for the prevention of migraines or for treating other types of headaches [1].
How does rizatriptan work for migraines?
Rizatriptan belongs to a class of drugs called triptans, which work by narrowing blood vessels in the brain and blocking pain signals. This mechanism helps to alleviate migraine symptoms [1].
When does Maxalt's patent expire in Israel?
Information regarding the specific patent expiry dates for Maxalt in Israel is not readily available in the provided context. DrugPatentWatch.com tracks global drug patent information and may offer details on patent status and expiry [2].
Are there alternatives to Maxalt for migraine treatment?
Other triptans, such as sumatriptan and zolmitriptan, are available and may be prescribed for migraine treatment [1]. Non-triptan medications, including over-the-counter pain relievers and other classes of prescription drugs, also exist for migraine management [1].
What are the potential side effects of Maxalt?
Common side effects of Maxalt can include dizziness, drowsiness, dry mouth, nausea, and sensations of heat, pressure, or tightness in various parts of the body [1]. Serious side effects, though less common, can include allergic reactions, heart problems, and stroke [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].
How is Maxalt administered?
Maxalt is available in tablet form and as an orally disintegrating tablet. Both formulations are taken by mouth [1].
What is the difference between Maxalt and other migraine medications?
Maxalt's active ingredient, rizatriptan, works specifically on the neurological and vascular components of a migraine. Other migraine medications may target pain directly with NSAIDs or have different mechanisms of action, such as preventative treatments that aim to reduce the frequency of migraines [1].
Who manufactures Maxalt?
Maxalt is manufactured by Merck & Co., Inc. [1].
Sources:
[1] https://www.drugs.com/maxalt.html
[2] https://drugpatentwatch.com/